Clinical Study

A Pilot Study on Bioactive Constituents and Analgesic Effects of MyrLiq®, a Commiphora myrrha Extract with a High Furanodiene Content

Table 1

Furanodiene content of MyrLiq. Data are expressed as the relative area percentage and content (standard deviation).

CompoundFuranodiene area percentageContent
(g kg−1)

Curzerene17.93 (0.20)12.31 (0.05)
Furanoeudesma-1,3-diene27.44 (0.17)18.84 (0.02)
Lindestrene 9.08 (0.06) 6.23 (0.01)
Unknown furanodiene (MW = 216) 0.44 (0.01) 0.30 (0.004)
Dihydrolinderalactone 1.91 (0.02) 1.31 (0.02)
Acetoxy-furanodiene (MW = 274) 0.87 (0.05) 0.59 (0.03)
Acetoxy-furanodiene (MW = 232) 1.85 (0.04) 1.27 (0.03)
Total59.51 (0.43)40.86 (0.78)